HEALTHSTREAM, INC. - FORM 10-Q/A
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Amendment No. 1 to FORM 10-Q)
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
For the quarterly period ended June 30, 2008
Commission File No.: 000-27701
HealthStream, Inc.
(Exact name of registrant as specified in its charter)
     
Tennessee   62-1443555
(State or other jurisdiction of   (I.R.S. Employer Identification No.)
incorporation or organization)    
     
209 10th Avenue South, Suite 450    
Nashville, Tennessee   37203
(Address of principal executive offices)   (Zip Code)
(615) 301-3100
(Registrant’s telephone number, including area code)
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
     
Large accelerated filer o
  Accelerated filer o
 
   
Non-accelerated filer o (Do not check if a smaller reporting company)
  Smaller reporting company x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of August 6, 2008, 21,528,728 shares of the registrant’s common stock were outstanding.
 
 

 


 

Explanatory Note
This amendment of the HealthStream, Inc. Form 10-Q for the quarter ended June 30, 2008, is to correct a typo in Note 7. Business Segments of the Notes to Condensed Consolidated Financial Statements.

 


 

HEALTHSTREAM, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
6. NET INCOME PER SHARE (continued)
The following table sets forth the computation of basic and diluted net income per share for three and six months ended June 30, 2008 and 2007:
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2008     2007     2008     2007  
Numerator:
                               
Net income
  $ 739,441     $ 424,709     $ 805,125     $ 469,258  
 
                       
 
                               
Denominator:
                               
Weighted average shares outstanding:
                               
Basic
    21,961,252       21,970,364       22,024,098       21,953,075  
Employee stock options and escrowed shares
    617,573       811,198       628,862       739,253  
 
                       
Diluted
    22,578,825       22,781,562       22,652,960       22,692,328  
 
                       
 
                               
Net income per share:
                               
Basic
  $ 0.03     $ 0.02     $ 0.04     $ 0.02  
 
                       
Diluted
  $ 0.03     $ 0.02     $ 0.04     $ 0.02  
 
                       
7. BUSINESS SEGMENTS
We provide our services to healthcare organizations, pharmaceutical and medical device companies, and other members within the healthcare industry. Our services are primarily focused on the delivery of education and training products and services (HealthStream Learning), as well as survey and research services (HealthStream Research). The accounting policies of the segments are the same as those described in the summary of significant accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2007.
We measure segment performance based on operating income (loss) before income taxes and prior to the allocation of certain corporate overhead expenses, interest income, interest expense, and depreciation. We have revised our measure of segment performance and are now allocating building and utility expenses to Learning, which had previously been included in Unallocated. We have also restated historical periods for both Learning and Unallocated to reflect the allocation of these corporate overhead expenses. The following is our business segment information as of and for the three and six months ended June 30, 2008 and 2007.
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2008     2007     2008     2007  
Revenues
                               
Learning
  $ 8,172,642     $ 6,497,960     $ 15,669,348     $ 12,976,519  
Research
    4,840,353       5,548,608       8,765,347       7,171,388  
 
                       
Total net revenue
  $ 13,012,995     $ 12,046,568     $ 24,434,695     $ 20,147,907  
 
                       
 
                               
Income (loss) from operations
                               
Learning
  $ 1,665,897     $ 560,484     $ 3,325,529     $ 1,968,507  
Research
    972,534       1,564,405       1,001,478       1,521,423  
Unallocated
    (1,914,175 )     (1,716,932 )     (3,558,801 )     (3,172,909 )
 
                       
Total income from operations
  $ 724,256     $ 407,957     $ 768,206     $ 317,021  
 
                       
                 
    June 30, 2008     December 31, 2007  
Segment assets
               
Learning *
  $ 15,241,897     $ 17,270,540  
Research *
    26,053,572       26,284,097  
Unallocated
    11,614,521       9,806,820  
 
           
Total assets
  $ 52,909,990     $ 53,361,457  
 
           
* Segment assets include accounts and unbilled receivables, goodwill, intangible assets, capitalized software feature enhancements, restricted cash, prepaid and other current assets, other assets, and certain property and equipment. Cash and cash equivalents are not allocated to individual segments, and are included within Unallocated. A significant portion of property and equipment assets are included within Unallocated.

1


 

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  HEALTHSTREAM, INC.
 
 
  By:   /s/ Gerard M. Hayden, Jr.    
    Gerard M. Hayden, Jr.   
August 12, 2008    Chief Financial Officer   

2


 

         
HEALTHSTREAM, INC.
EXHIBIT INDEX
         
  31.1    
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
       
 
  31.2    
Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
       
 
  32.1    
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
       
 
  32.2    
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

3